Benjamin E Blass

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Molecular Dynamics Simulations

Respiratory Syndrome Coronavirus

Replacement Therapy

Top Venues

ACS medicinal chemistry letters

Journal of chemical information and modeling

ACS chemical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin E Blass
Inhibitors of Na v 1.7 for the Treatment of Pain. ACS medicinal chemistry letters 13 (4) (2022)
Hamed S Hayatshahi, Robert R Luedtke, Michelle Taylor, Peng-Jen Chen, Benjamin E Blass, Jin Liu
Factors Governing Selectivity of Dopamine Receptor Binding Compounds for D2R and D3R Subtypes. Journal of chemical information and modeling 61 (6) (2021)
Anjela Manandhar, Benjamin E Blass, Dennis J Colussi, Imane Almi, Magid A Abou-Gharbia, Michael L Klein, Khaled M Elokely
Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening. Journal of chemical information and modeling 61 (2) (2021)
Benjamin E Blass
Cyclic ADP Ribose Hydrolase (CD38) Inhibitors. ACS medicinal chemistry letters 13 (1) (2021)
Benjamin E Blass
Pyrrolo-pyridazine Derivatives as Muscarinic M1 Receptor Positive Allosteric Modulators. ACS medicinal chemistry letters 12 (5) (2021)
Kevin M Blattner, Daniel J Canney, Douglas A Pippin, Benjamin E Blass
Pharmacology and Therapeutic Potential of the 5-HT7 Receptor. ACS chemical neuroscience 10 (1) (2018)